US Stock Alert: Caterpillar tanked on October 7 due to target price downgrade, AI concerns, and valuation correction
Bitget异动解读2026/10/07 14:05Caterpillar October 7 Sharp Decline Analysis
Keywords: Target Price Cut, AI Concerns, Valuation Adjustment
1. On October 7, rising U.S. Treasury yields and weakening Dow futures put pressure on industrial stocks as a whole, with Caterpillar retreating along with the sector.
2. On October 5, analysts lowered Caterpillar’s target price from $1,225 to $1,100, citing uncertainties regarding the sustainability of data center and artificial intelligence spending, infrastructure bottlenecks, and high input costs.
3. On October 6, data showed Caterpillar’s price-to-earnings ratio was about 36 times, with its stock price rising approximately 74.4% over the past 12 months. Against a background of high valuation, there was profit-taking and pressure for valuation correction.
(Disclaimer: This content is generated by AI technology from publicly available information and is for reference only. It does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Dollar Retreat Boosts Gold Prices as Market Weighs Federal Reserve Rate Hike Path
1. On Thursday, as the US dollar retreated from its 18-month high, gold prices rebounded from a two-month low. As of 10:25, spot gold rose as much as 0.74% to $4140.08 per ounce. The weaker dollar reduced the purchase cost of gold for buyers using other currencies, thereby supporting gold prices. On Wednesday, gold prices had touched their lowest level since August 5 due to a stronger dollar and rising US Treasury yields. In the Asian session on Thursday, the US dollar index edged down by 0.1%, trading near 102.16. 2. Chris Weston, head of research at Pepperstone, stated that the short-term outlook for gold remains rather bearish and it is still a seller’s market. Gold prices need to break above $4275 for a more optimistic near-term outlook. He pointed out that if the market starts viewing the rise in long-term yields as a reflection of sovereign credit and fiscal risks rather than a signal of strong economic performance, gold might start moving in tandem with bond yields, and currency devaluation trades could heat up again. 3. Minutes from the Federal Reserve's September meeting showed that policymakers were divided on the need for a rate hike. Some participants argued that a rate increase was necessary to offset the effects of energy and other price shocks; more hawkish core members advocated for a hike to guard against newly emerging demand-driven inflation. According to the CME FedWatch tool, traders assign only an 18% probability of a rate hike later this month, but expect the probability of a December hike to be as high as 80%. Rising interest rates usually dampen the appeal of non-yielding gold. 4. IMF President Kristalina Georgieva warned that the global economy is under threat from persistently high energy prices, record levels of public debt, and risks from an artificial intelligence investment boom, and urged governments to adopt protective fiscal and monetary policy measures.
Domestic gold jewelry price adjustment on October 8: Lao Miao drops by 10 yuan, Chow Sang Sang and Lao Feng Xiang drop by 4 yuan.
(1) On October 8, a comparison of domestic gold jewelry prices showed that several gold jewelry brands in China adjusted their domestic pure gold jewelry prices compared to the previous day. (2) Lao Miao Gold quoted at 1,243 yuan/gram, down 10 yuan from the previous day. (3) Chow Sang Sang quoted at 1,248 yuan/gram, down 4 yuan from the previous day. (4) Chow Tai Fook quoted at 1,249 yuan/gram, unchanged from the previous day. (5) Lao Feng Xiang quoted at 1,247 yuan/gram, down 4 yuan from the previous day.
Pfizer (PFE.US) Tukysa receives U.S. approval for first-line breast cancer treatment
According to Zhitong Finance APP, Pfizer (PFE.US) announced on Wednesday that the U.S. Food and Drug Administration (FDA) has approved its tyrosine kinase inhibitor Tukysa (tucatinib) as part of a combination therapy for first-line maintenance treatment of a certain type of breast cancer.
Xpeng Robotaxi launches its Chinese name "Xpeng Youyou" and expands the range of internal test users
On October 8, XPeng Group officially launched the Chinese name "小鹏悠游" for its Robotaxi business, with the English name "XPENGYOYO". On the same day, the official XPeng Group website went live with a Robotaxi product page, and the online ordering mini-program "XPENGYOYO Autonomous Driving" was launched simultaneously. The company will further expand the scope of its internal testing users by distributing invitation codes. This marks XPeng Robotaxi’s official transition from technology verification to a new phase of user access and business exploration.